0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Detection Methods Gut & Microbiome Human Health Effects Remediation Sign in to save

The Effects of Immunosuppression on the Lung Microbiome and Metabolites in Rats

Frontiers in Microbiology 2022 7 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 40 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Huiwei Dong, Rong Tan, Zhengshan Chen, Lifang Wang, Yuanyuan Song, Min Jin, Jing Yin, Haibei Li, Jùnwén Lǐ, Dong Yang

Summary

Researchers investigated the lung microbiome and metabolites in immunosuppressed rats to clarify whether pneumonia in this population arises from inhaled oropharyngeal pathogens or abnormal proliferation of pulmonary proteobacteria. The study used a cyclophosphamide-induced immunosuppression model to characterize shifts in the respiratory microbial community.

Immunosuppressed patients are more likely to suffer from pneumonia, especially Streptococcus and Enterobacter pneumonia. Studies have demonstrated the existence of a complex and dynamic microbiota on the surface of human respiratory epithelial cells, both in healthy and diseased states. However, it is not clear whether the pneumonia in immunosuppressed patients is caused by inhaled oropharyngeal pathogens or abnormal proliferation of pulmonary proteobacteria. In this study, immunosuppressed model was made by intraperitoneal injection of cyclophosphamide and oropharyngeal saliva aspiration was simulated by oral and pharyngeal tracheal instillation of sterilized phosphate buffered saline (PBS). Furthermore, the effects of immunosuppression on the lung microbial community and its metabolism were investigated using 16S rRNA gene sequencing and liquid chromatography-mass spectrometry (LC-MS) metabolomics analysis. The 16S rRNA gene sequencing results showed that immunosuppression alone did not change the composition of pulmonary bacteria. Moreover, although the bacteria brought by sterilized PBS from oropharynx to lower respiratory tract changed the composition of the microflora in healthy and immunosuppressed rats, the change in the latter was more obvious. Metabolomic analysis revealed that the levels of pulmonary metabolites were disturbed in the immunosuppressed rats. The altered lung microbiota, including Streptococcaceae and Enterobacteriaceae, showed significant positive correlations with pulmonary metabolites. Our study suggested that the source of the pathogens of pneumonia in immunosuppressed rats was via inhalation and explored the relationship between lung microbiome and metabolites in immunosuppressed rats. Our results provide the basis for the development of prevention and treatment strategies for pneumonia.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Gut-lung microbiota dynamics in mice exposed to Nanoplastics

Researchers gave mice PET nanoplastics orally for 28 days and analyzed the microbiome in their lungs, colon, mouth, and stool. While gut and oral bacteria were relatively unchanged, the lung microbiome showed significant shifts, including increases in bacteria associated with respiratory inflammation. The findings suggest a gut-lung connection where ingested nanoplastics may influence lung microbial communities even when gut bacteria appear unaffected.

Article Tier 2

Microplastics exposed by respiratory tract and exacerbation of community-acquired pneumonia: The potential influences of respiratory microbiota and inflammatory factors

Researchers found that microplastics were present in the lungs of pneumonia patients, and that patients with severe pneumonia had higher levels of microplastics in their airways than those with milder cases. The microplastics appeared to worsen lung infections by disrupting the balance of airway bacteria and increasing inflammation. This study provides early evidence that inhaled microplastics may make respiratory infections more dangerous in humans.

Article Tier 2

Effects of combined exposure to heavy metals on lower respiratory flora and its role of lung injury in rats

Researchers found that combined exposure to nickel, copper, and arsenic disrupted the natural microbial communities in the lower respiratory tract of rats and caused lung damage. The heavy metal mixture altered the balance of beneficial and harmful bacteria in the airways, which was linked to impaired lung function. The findings highlight how environmental exposure to multiple metals simultaneously may harm respiratory health by disrupting the lung's natural microbiome.

Article Tier 2

Breathing plastics: Influence of airborne microplastics on the respiratory microbiome and health of human lungs (Review)

Researchers reviewed evidence showing that inhaled airborne microplastics can physically interact with the microbial community living in human lungs, disrupting its balance and triggering inflammation linked to conditions like asthma and fibrosis. Because microplastic particles have been found in lung tissue and fluid samples, inhalation is now recognized as a significant exposure route with measurable consequences for respiratory health.

Article Tier 2

Detrimental effects of microplastic exposure on normal and asthmatic pulmonary physiology

Researchers exposed both healthy and asthmatic mice to airborne microplastics and found significant lung inflammation, immune activation, and increased mucus production in both groups. Microplastic particles were taken up by immune cells called macrophages, and gene analysis revealed changes in immune response, cellular stress, and cell death pathways. The study suggests that inhaling microplastics may worsen respiratory health in both normal and vulnerable populations.

Share this paper